SightfileU.S. market data from official filings

VERACYTE INC (VCYT)

Name: VERACYTE INC (VCYT) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001384101 · EDGAR filings · Updated 2026-06-22

VERACYTE INC (VCYT) has reported institutional ownership of 110.6%, with 334 institutional managers holding positions valued at $2.84B per the latest 13F reporting period.

Institutional ownership

110.6%

Institutional managers

334

Reported 13F value

$2.84B

Insider activity

104 trans.

−$11.5M net selling

Latest updates

2026-06-22 — Insider transaction reported (Form 4)
2026-06-18 — Notice of proposed sale filed (Form 144)
2026-06-15 — Insider transaction reported (Form 4)
2026-06-15 — Insider transaction reported (Form 4)
2026-06-15 — Insider transaction reported (Form 4)
2026-06-15 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, VERACYTE INC has 334 institutional holders and institutional ownership of 110.6%.

Insider activity

Insiders reported 104 transactions (0 buys, 45 sells) across 14 reporting insiders, with a net reported value of −$11.5M.

Related companies

HIMS & HERS HEALTH INC (HIMS) · TRAVERE THERAPEUTICS INC (TVTX) · SUPERNUS PHARMACEUTICALS (SUPN) · DENALI THERAPEUTICS INC (DNLI) · CARIS LIFE SCIENCES INC (CAI) · IMMUNOVANT INC (IMVT)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-22.